Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients

NCT02479399 · clinicaltrials.gov ↗

COMPLETED

Status

11412

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: ipragliflozin

Sponsor

Astellas Pharma Inc